Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion type Assertion NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_head.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion description "[These findings strongly favour a recommendation for MEN1 and CASR genotyping of patients with multiglandular FIHP, irrespective of urinary calcium excretion. However, it appears that HRPT2 genotyping should be reserved for cases in which other features of]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_provenance.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion evidence source_evidence_literature NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_provenance.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion SIO_000772 14985373 NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_provenance.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion wasDerivedFrom gad-20150221 NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_provenance.
- NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_assertion wasGeneratedBy ECO_0000203 NP68791.RAHl5kFe1-asMENVG3b3bOw-za0wSvLA0ivz3Oc5iNHgE130_provenance.